Pharmaceutical Business review

InnoPharma launches Cosyntropin injection, 0.25mg/vial in US

Cosyntropin injection, 0.25mg/vial available in single-use vials is generic equivalent of Cortrosyn injection.

Cosyntropin injection is indicated for use as a diagnostic agent to detect patients with suspected adrenocortical insufficiency.

InnoPharma develops complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms.